a public good project by the
Synthesis
Company
of California

© 2026

Hoau-Yan Wang | doi.page

0 works0 citations0 h-index

Hoau-Yan Wang

City University of New York(US)New York Medical College(US)

Publications by Year

Research Areas

Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Protein Kinase Regulation and GTPase Signaling

Most-Cited Works

→ Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline(2012)1,804 cited
→ β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity(2000)802 cited
→ Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia(2006)564 cited
→ α7 Nicotinic Acetylcholine Receptors Mediate β-Amyloid Peptide-induced Tau Protein Phosphorylation(2003)184 cited
→ Cortical Plasticity in Alzheimer’s Disease in Humans and Rodents(2007)174 cited
→ The nature, significance, and glucagon‐like peptide‐1 analog treatment of brain insulin resistance in Alzheimer's disease(2014)135 cited

→ D1-like Dopaminergic Activation of Phosphoinositide Hydrolysis Is Independent of D1A Dopamine Receptors: Evidence from D1A Knockout Mice(1997)

121 cited

→ Attenuated protein kinase C activity and translocation in Alzheimer's Disease brain(1994)121 cited

→ In UteroCocaine-Induced Dysfunction of Dopamine D₁Receptor Signaling And Abnormal Differentiation of Cerebral Cortical Neurons(2000)108 cited

→ Dissociating β-Amyloid from α7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes α7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain(2009)101 cited